company background image
NVTA.Q logo

Invitae OTCPK:NVTA.Q Stock Report

Last Price

US$0.0004

Market Cap

US$114.6k

7D

0%

1Y

-100.0%

Updated

05 Aug, 2024

Data

Company Financials

Invitae Corporation

OTCPK:NVTA.Q Stock Report

Market Cap: US$114.6k

NVTA.Q Stock Overview

A medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. More details

NVTA.Q fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Invitae Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Invitae
Historical stock prices
Current Share PriceUS$0.0004
52 Week HighUS$1.25
52 Week LowUS$0.000001
Beta2.8
11 Month Change-42.86%
3 Month Change-76.47%
1 Year Change-99.97%
33 Year Change-100.00%
5 Year Change-100.00%
Change since IPO-100.00%

Recent News & Updates

Recent updates

Cautious Investors Not Rewarding Invitae Corporation's (NYSE:NVTA) Performance Completely

Dec 20
Cautious Investors Not Rewarding Invitae Corporation's (NYSE:NVTA) Performance Completely

Invitae: Revenue Troubles Build

Aug 09

Invitae Is Treading In Competitive Waters

Jul 16

Invitae Corporation's (NYSE:NVTA) Prospects Need A Boost To Lift Shares

Jun 26
Invitae Corporation's (NYSE:NVTA) Prospects Need A Boost To Lift Shares

Invitae: What Happened At The JP Morgan Health Conference

Jan 19

Invitae guides Q4 revenue above estimates

Jan 09

Invitae Likely Hasn't Reached The Bottom Yet

Dec 15

Invitae: This Turnaround Could Be Painful

Nov 15

Invitae GAAP EPS of -$1.27 misses by $0.43, revenue of $133.54M beats by $2.16M

Nov 08

Invitae Stock: Losses And Debt Suggest Bearish Sentiment Is Deserved

Sep 22

Why Invitae Corporation Could Underperform

Aug 17

Invitae maintains 2022 financial guidance as Q2 results beat on top and bottom lines

Aug 09

Shareholder Returns

NVTA.QUS HealthcareUS Market
7D0%3.3%2.2%
1Y-100.0%4.9%32.6%

Return vs Industry: NVTA.Q underperformed the US Healthcare industry which returned 8.6% over the past year.

Return vs Market: NVTA.Q underperformed the US Market which returned 15.9% over the past year.

Price Volatility

Is NVTA.Q's price volatile compared to industry and market?
NVTA.Q volatility
NVTA.Q Average Weekly Movement642.7%
Healthcare Industry Average Movement6.6%
Market Average Movement6.3%
10% most volatile stocks in US Market15.8%
10% least volatile stocks in US Market3.1%

Stable Share Price: NVTA.Q's share price has been volatile over the past 3 months.

Volatility Over Time: NVTA.Q's weekly volatility has increased from 571% to 643% over the past year.

About the Company

FoundedEmployeesCEOWebsite
20101,700Ken Knightwww.invitae.com

Invitae Corporation, a medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases, and pharmacogenomics; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners.

Invitae Corporation Fundamentals Summary

How do Invitae's earnings and revenue compare to its market cap?
NVTA.Q fundamental statistics
Market capUS$114.60k
Earnings (TTM)-US$1.44b
Revenue (TTM)US$481.58m

0.0x

P/S Ratio

0.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NVTA.Q income statement (TTM)
RevenueUS$481.58m
Cost of RevenueUS$350.95m
Gross ProfitUS$130.64m
Other ExpensesUS$1.57b
Earnings-US$1.44b

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-5.03
Gross Margin27.13%
Net Profit Margin-299.14%
Debt/Equity Ratio-124.7%

How did NVTA.Q perform over the long term?

See historical performance and comparison